Preoperative therapy in breast cancer: Lessons from the treatment of locally advanced disease

Oncologist

Volumn 7, Issue 3, 2002, Pages 239-245

  Wolff, Antonio C ^a   Davidson, Nancy E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Locally advanced disease; Neoadjuvant theraphy; Preoperative theraphy

Indexed keywords

AMINOGLUTETHIMIDE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; TAMOXIFEN; VINCRISTINE;

BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TAMOXIFEN;

EID: 0036079286     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.7-3-239     Document Type: Review

References (46)

1. The results of operations for the cure of cancer of the breast performed at Johns Hopkins Hospital from June 1889 to January 1894
2. Carcinoma of the breast. II. Criteria of operability
3. A personal experience with Halsted's radical mastectomy
4. Treatment of locally advanced breast cancer
5. Tamoxifen for early breast cancer: An overview of the randomised trials
6. Polychemotherapy for early breast cancer: An overview of the randomised trials
7. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience
8. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A Cancer and Leukemia Group B study
9. Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery
10. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: A European Organization for Research and Treatment of Cancer Randomized Phase III Trial
11. Long-term follow-up of a randomized trial on adjuvant chemotherapy and hormonal therapy in locally advanced breast cancer
12. Locally advanced breast cancer: Report of phase II study and subsequent phase III trial
13. Locally advanced breast cancer: Early results of a randomised trial of multimodal therapy versus initial hormone therapy
14. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial
15. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
16. The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group
17. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice
18. Presence of a growth-stimulating factor in serum following primary tumor removal in mice
19. Neoadjuvant chemotherapy in 126 operable breast cancers
20. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer
21. Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute
22. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
23. Weekly paclitaxel (P) followed by FAC in the neo-adjuvant setting provides improved pathologic complete remission (PCR) rates compared to standard paclitaxel followed by FAC therapy-preliminary results of an ongoing prospective randomized trial
24. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy
25. A randomized double-blind multicenter study of preoperative tamoxifen versus Femara (letrozole) for postmenopausal women with ER and/or PgR positive breast cancer ineligible for breast-conserving surgery. Correlation of clinical response with tumor expression and proliferation
26. Preoperative (neoadjuvant-PRE) versus postoperative (POST) adjuvant chemotherapy (CT) for stage I-II breast cancer (SI-II BC). Long-term analysis of British Columbia randomized trial
27. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre
28. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up
29. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
30. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
31. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
32. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
33. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
34. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
35. The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: Preliminary results from NSABP Protocol B-27
36. Primary chemotherapy in the treatment of breast cancer: Significantly enhanced clinical and pathological response with docetaxel
37. Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies
38. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status
39. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy
40. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
41. Neoadjuvant chemotherapy contraindicates sentinel node mapping in breast cancer
42. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
43. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma
44. Feasibility of immediate breast reconstruction for locally advanced breast cancer
45. Can we cure limited metastatic breast cancer?